Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02636387 · ClinicalTrials.gov registry record
Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease
A clinical trial, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- 14
- Enrollment target
NCT02636387 is a clinical trial that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT02636387 was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease.
Interventions
- DRUG Desmopressin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2015-08-26 |
| Est. Completion | 2018-10-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02636387
The ClinicalTrials.gov registry entry for NCT02636387 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Desmopressin is the first listed.
NCT02636387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02636387 about?
NCT02636387 is a clinical study titled "Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease". This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease.
What is the current status of trial NCT02636387?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2015-08-26. Estimated completion is 2018-10-27.
What interventions are being tested in trial NCT02636387?
The interventions under investigation include: Desmopressin (DRUG).
Who is sponsoring clinical trial NCT02636387?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.